Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cerebain (PKG) is only manufacturing the mask. They do not own the patents.
Perhaps we're getting into the end of year, loss selling for tax purposes phase. Enzolytics is down quite a bit today too, and they have been filing their past due 10Ks and 10Qs. I'm thinking pennyland will be mostly red through the end of the year.
Right, but that generally happens when their is disagreement over something. And if that's the case, then it seems that due diligence is being done on the back end, instead of up front.
That's a fair point, though contract and document review can be done remotely. Now, if one or more of the auditors fell ill, then sure, that would impact timelines. It's not an unreasonable assumption, but doesn't seem probable.
It's also possible that the deal is in limbo, and that PKG won't remove that statement unless they know definitively that the deal is off. I expect that if the deal were to be called off, both parties would make an announcement.
It seems that this one last document, being the bone of contention, must contain a real doozy. They've been wrong on how long it would take to iron it out, so that tells me that there's something of concern, significance, or uncertainty within it.
This is getting a bit ridiculous. I'm OK with waiting, but it shouldn't take this long to get a 10K out, unless something significant was missed...or discovered. The estimated timeline has been missed by more than twice said estimate.
Sanity readjustment - expecting this deal to close by the end of March 2021.
I understand his frustration. Enzloytics' progress on SEC filings is keeping it together for me LOL.
https://sec.report/Ticker/enzc
Yep, holding strong.
More than ever, I hope they do give us that hinted at update this week.
Was just checking PKG's News section of their website - no mention of Cerebain acquiring them. To be fair, I don't recall if it was ever posted there or not, but I find it a bit odd that while they mentioned it on their social media pages, they don't have it up on their website.
In the 11/25 update re: Clearmask, they do clearly outline the Cerebain deal, but why not post a full article about the acquisition?
Yes, I am nitpicking.
Over a few weeks, PKG Inc. will fully transition company ownership to the Cerebain Biotech Corporation in an acquisition that began in the middle of this year. Upon completion, under the Cerebain Biotech umbrella, PKG Inc. will continue its support in mass-producing large volumes of the FDA-cleared ClearMask™. "We are proud to help ClearMask fight against the pandemic with a smile on our face that everyone can see." -- ALMIR GARIBOVIC, PRESIDENT OF PKG
https://www.pkguis.com/news
I'd love to know what this 'one last document' which is holding up completion of the deal is. Any ideas?
"The waaaaiiiiitttttinnnng is the HARDEST PART!" - Tom Petty
Yeah, but that dang good reason could simply be that they are being thorough, and ensuring the that filings are properly audited prior to release. That should be a given anyway, but this is the OTC. The fact that they didn't file for a year is a bit concerning. To me, getting current, will make them 'whole' once more. Right now, they are at a deficit.
I think filings send this to the .10-.20 range, esp. if they're as good as some here expect.
Oddly enough, I was just able to get to their site from a different network. The site looks as it always has. But, as to why I can get to it from one network but not another, I can only assume that not all CDNs (content distribution networks) have yet updated with the most current copy of the website. And whether that most recent copy is the offline or online version is anyone's guess.
Good, looks like they renewed registration at some point today.
They may have already switched to a new domain, in support of the soon to be merged entity with PKG.
According the registration records, cerebain.com expired on 11/26/20. That impacts all services hosted on the domain, including web services and email.
It's odd to do maintenance during business hours. More likely is that they forgot to re-register their domain over the holiday weekend when it expired, and they are now (hopefully) working with their registar
and host to restore services.
Not weird, since the domain cerebain.com is no longer registered. The domain registration impacts all resources that rest upon it, including the website and e-mail.
I still can't access it.
I think so, likely just part of the reorg strategy...IMO.
It also expired over a holiday weekend, so could just as easily be an oversight.
cerebain.com is expired, and no longer registered. Either they purposely have abandoned the domain, or perhaps with all that's going on with the merger, they forgot to renew it.
Try to access this link: http://www.cerebain.com/investorsmedia/
Do you see the expired message from GoDaddy?
Another possibility is that they've registered a completely new domain in anticipation of the merged entity with PKG. For that matter, perhaps they just assume PKG's identity and use their website going forward.
According to domaintools.com, cerebain.com registration expired on 11.26.20. Hopefully they renewed it and are just in the process of revamping the website. But if they in fact, failed to renew their domain registration, that too could explain why the site is down.
Domain Name: CEREBAIN.COM
Registry Domain ID: 1572687218_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-11-27T15:02:17Z
Creation Date: 2009-10-18T16:32:57Z
Registrar Registration Expiration Date: 2020-11-26T11:59:59Z
Yep, kinda odd given yesterday's action.
Yep, expectations re-adjusted for the deal to close by end of year.
PKG posted the mask production news on their website:
https://www.pkguis.com/news-content/2020/11/25/see-the-person-not-the-mask
Happy Thanksgiving everyone!
Cerebain owns PKG. PKG will manufacture the masks for Clearmask. And Xometry is the middle-man that brokered the deal between Clearmask and PKG.
To meet the rigorous controls necessary for FDA-cleared products, ClearMask LLC and Xometry, the largest marketplace for On-Demand manufacturing, partnered with PKG Inc., an ISO 13485-certified facility, to manufacture the FDA-cleared version of the ClearMask™. PKG will provide valuable experience in building FDA-approved products, enabling mass production while achieving rigorous oversight and high quality.
This November, PKG Inc. officially kick-started a new production floor designed to meet the mass production of the FDA-cleared ClearMask™, which has been in high demand.
Let's not forget about the internet boom of 1999-2000, either. Adding a .com to the end of a company name doesn't make it any more viable LOL.
It's a holiday week, I doubt there will be any press releases or updates. I'm guessing that much like most Americans, they will be relaxing, eating, and watching football.
I doubt it goes up until a formalized plan to resume clinical trials is established. Thus far they've announced their intent to resume trials, but there is no actual plan, with time lines, chosen test sites, patient enrollment numbers, metrics for success, DSMB members, etc.
Until then, it's just a concept.
No timeline was given in the update last week. Final stages does not set a specific time frame.
Granted, the e-mail stated a couple weeks, and I believe we are now pushing up against the end of it.
Cerebain is in the final stages of its acquisition of PKG, Inc. In combination with the closing of the acquisition of PKG, Cerebain intends to bring the Company’s SEC filings current.
Upon the completion of the acquisition, Cerebain will initiate a review of its overall business and corporate strategic plan. The corporate strategic initiatives to be developed and implemented include, but are not limited to, rebranding and repositioning of the Company’s overall business plan and a comprehensive growth strategy focused on revenue generation through a comprehensive roll-up acquisition strategy of target qualified candidates in select industries.
Well stated, these are the same thoughts and questions I have.
Consider another penny bio-tech, Enzolytics (ENZC). They are merging with another company and much like CBBT, were behind on their filings. Yet they've been updating and posting them, little by little, showing progress, which in turn helps maintain confidence.
https://www.otcmarkets.com/stock/ENZC/disclosure
Asking CBBT to do the same in a timely manner is not unreasonable.
I agree that it's always best to under promise, and hopefully over deliver. The reverse never leaves a good impression.
Interesting. Is that an observable trend you've seen repeated on various message boards?